
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations
Silvia Affò, Ajay Nair, Francesco Brundu, et al.
Cancer Cell (2021) Vol. 39, Iss. 6, pp. 866-882.e11
Open Access | Times Cited: 267
Silvia Affò, Ajay Nair, Francesco Brundu, et al.
Cancer Cell (2021) Vol. 39, Iss. 6, pp. 866-882.e11
Open Access | Times Cited: 267
Showing 1-25 of 267 citing articles:
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
Karin E. de Visser, Johanna A. Joyce
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 374-403
Open Access | Times Cited: 1408
Karin E. de Visser, Johanna A. Joyce
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 374-403
Open Access | Times Cited: 1408
Clinical and therapeutic relevance of cancer-associated fibroblasts
Yang Chen, Kathleen M. McAndrews, Raghu Kalluri
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 12, pp. 792-804
Open Access | Times Cited: 725
Yang Chen, Kathleen M. McAndrews, Raghu Kalluri
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 12, pp. 792-804
Open Access | Times Cited: 725
Cholangiocarcinoma
Paul J. Brindley, Melinda Bachini, Sumera I. Ilyas, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 495
Paul J. Brindley, Melinda Bachini, Sumera I. Ilyas, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 495
Cancer-associated fibroblasts in the single-cell era
Dor Lavie, Aviad Ben‐Shmuel, Neta Erez, et al.
Nature Cancer (2022) Vol. 3, Iss. 7, pp. 793-807
Open Access | Times Cited: 322
Dor Lavie, Aviad Ben‐Shmuel, Neta Erez, et al.
Nature Cancer (2022) Vol. 3, Iss. 7, pp. 793-807
Open Access | Times Cited: 322
Molecular pathogenesis and systemic therapies for hepatocellular carcinoma
Josep M. Llovet, Roser Pinyol, Robin Kate Kelley, et al.
Nature Cancer (2022) Vol. 3, Iss. 4, pp. 386-401
Open Access | Times Cited: 270
Josep M. Llovet, Roser Pinyol, Robin Kate Kelley, et al.
Nature Cancer (2022) Vol. 3, Iss. 4, pp. 386-401
Open Access | Times Cited: 270
Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis
Aveline Filliol, Yoshinobu Saito, Ajay Nair, et al.
Nature (2022) Vol. 610, Iss. 7931, pp. 356-365
Open Access | Times Cited: 186
Aveline Filliol, Yoshinobu Saito, Ajay Nair, et al.
Nature (2022) Vol. 610, Iss. 7931, pp. 356-365
Open Access | Times Cited: 186
Cancer-associated fibroblasts: from basic science to anticancer therapy
Dakai Yang, Jing Liu, Hui Qian, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 7, pp. 1322-1332
Open Access | Times Cited: 182
Dakai Yang, Jing Liu, Hui Qian, et al.
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 7, pp. 1322-1332
Open Access | Times Cited: 182
Spatial Positioning and Matrix Programs of Cancer-Associated Fibroblasts Promote T-cell Exclusion in Human Lung Tumors
John A. Grout, Philémon Sirven, Andrew M. Leader, et al.
Cancer Discovery (2022) Vol. 12, Iss. 11, pp. 2606-2625
Open Access | Times Cited: 167
John A. Grout, Philémon Sirven, Andrew M. Leader, et al.
Cancer Discovery (2022) Vol. 12, Iss. 11, pp. 2606-2625
Open Access | Times Cited: 167
Pancreatic Tumor Microenvironment Factor Promotes Cancer Stemness via SPP1–CD44 Axis
Palanisamy Nallasamy, Rama Krishna Nimmakayala, Saswati Karmakar, et al.
Gastroenterology (2021) Vol. 161, Iss. 6, pp. 1998-2013.e7
Open Access | Times Cited: 165
Palanisamy Nallasamy, Rama Krishna Nimmakayala, Saswati Karmakar, et al.
Gastroenterology (2021) Vol. 161, Iss. 6, pp. 1998-2013.e7
Open Access | Times Cited: 165
Targeting the tumor stroma for cancer therapy
Maosen Xu, Tao Zhang, Ruolan Xia, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 154
Maosen Xu, Tao Zhang, Ruolan Xia, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 154
Activated fibroblasts in cancer: Perspectives and challenges
Giuseppina Caligiuri, David A. Tuveson
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 434-449
Open Access | Times Cited: 153
Giuseppina Caligiuri, David A. Tuveson
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 434-449
Open Access | Times Cited: 153
CD36+ cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor
Guiqi Zhu, Zheng Tang, Run Huang, et al.
Cell Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 149
Guiqi Zhu, Zheng Tang, Run Huang, et al.
Cell Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 149
Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials
Hao Zhang, Xinghai Yue, Zhe Chen, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 139
Hao Zhang, Xinghai Yue, Zhe Chen, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 139
Immune Modulatory Properties of Collagen in Cancer
Anne Mette Askehøj Rømer, Marie‐Louise Thorseth, Daniel H. Madsen
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 134
Anne Mette Askehøj Rømer, Marie‐Louise Thorseth, Daniel H. Madsen
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 134
Cancer-Associated Fibroblasts: Tumorigenicity and Targeting for Cancer Therapy
Raisa A. Glabman, Peter L. Choyke, Noriko Sato
Cancers (2022) Vol. 14, Iss. 16, pp. 3906-3906
Open Access | Times Cited: 134
Raisa A. Glabman, Peter L. Choyke, Noriko Sato
Cancers (2022) Vol. 14, Iss. 16, pp. 3906-3906
Open Access | Times Cited: 134
Cancer-associated fibroblasts suppress ferroptosis and induce gemcitabine resistance in pancreatic cancer cells by secreting exosome-derived ACSL4-targeting miRNAs
Ran Qi, Yixuan Bai, Kun Li, et al.
Drug Resistance Updates (2023) Vol. 68, pp. 100960-100960
Open Access | Times Cited: 134
Ran Qi, Yixuan Bai, Kun Li, et al.
Drug Resistance Updates (2023) Vol. 68, pp. 100960-100960
Open Access | Times Cited: 134
Signaling pathways in cancer‐associated fibroblasts: recent advances and future perspectives
Zengli Fang, Qingcai Meng, Jin Xu, et al.
Cancer Communications (2022) Vol. 43, Iss. 1, pp. 3-41
Open Access | Times Cited: 126
Zengli Fang, Qingcai Meng, Jin Xu, et al.
Cancer Communications (2022) Vol. 43, Iss. 1, pp. 3-41
Open Access | Times Cited: 126
Identification, discrimination and heterogeneity of fibroblasts
Urban Lendahl, Lars Muhl, Christer Betsholtz
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 118
Urban Lendahl, Lars Muhl, Christer Betsholtz
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 118
Interferon-dependent SLC14A1+ cancer-associated fibroblasts promote cancer stemness via WNT5A in bladder cancer
Zikun Ma, Xiangdong Li, Yize Mao, et al.
Cancer Cell (2022) Vol. 40, Iss. 12, pp. 1550-1565.e7
Open Access | Times Cited: 110
Zikun Ma, Xiangdong Li, Yize Mao, et al.
Cancer Cell (2022) Vol. 40, Iss. 12, pp. 1550-1565.e7
Open Access | Times Cited: 110
Cellular senescence and the tumour microenvironment
Masaki Takasugi, Yuya Yoshida, Naoko Ohtani
Molecular Oncology (2022) Vol. 16, Iss. 18, pp. 3333-3351
Open Access | Times Cited: 90
Masaki Takasugi, Yuya Yoshida, Naoko Ohtani
Molecular Oncology (2022) Vol. 16, Iss. 18, pp. 3333-3351
Open Access | Times Cited: 90
Cholangiocarcinoma — novel biological insights and therapeutic strategies
Sumera I. Ilyas, Silvia Affò, Lipika Goyal, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 7, pp. 470-486
Open Access | Times Cited: 87
Sumera I. Ilyas, Silvia Affò, Lipika Goyal, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 7, pp. 470-486
Open Access | Times Cited: 87
Immunology and immunotherapy of cholangiocarcinoma
Tim F. Greten, Robert F. Schwabe, Nabeel Bardeesy, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 6, pp. 349-365
Closed Access | Times Cited: 85
Tim F. Greten, Robert F. Schwabe, Nabeel Bardeesy, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 6, pp. 349-365
Closed Access | Times Cited: 85
Desmoplastic stroma restricts T cell extravasation and mediates immune exclusion and immunosuppression in solid tumors
Zebin Xiao, Leslie Todd, Li Huang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 85
Zebin Xiao, Leslie Todd, Li Huang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 85
Novel microenvironment-based classification of intrahepatic cholangiocarcinoma with therapeutic implications
Miguel A. Martín-Serrano, Benjamin Kepecs, Miguel Torres‐Martín, et al.
Gut (2022) Vol. 72, Iss. 4, pp. 736-748
Open Access | Times Cited: 84
Miguel A. Martín-Serrano, Benjamin Kepecs, Miguel Torres‐Martín, et al.
Gut (2022) Vol. 72, Iss. 4, pp. 736-748
Open Access | Times Cited: 84
Single‐Nucleus RNA Sequencing and Spatial Transcriptomics Reveal the Immunological Microenvironment of Cervical Squamous Cell Carcinoma
Zhihua Ou, Shitong Lin, Jiaying Qiu, et al.
Advanced Science (2022) Vol. 9, Iss. 29
Open Access | Times Cited: 70
Zhihua Ou, Shitong Lin, Jiaying Qiu, et al.
Advanced Science (2022) Vol. 9, Iss. 29
Open Access | Times Cited: 70